0.6919
0.39%
0.0027
Phio Pharmaceuticals Corp (PHIO) 最新ニュース
Phio Pharmaceuticals expands incentive plan following shareholder approval By Investing.com - Investing.com Canada
Investing.com Canada
Phio Pharmaceuticals expands incentive plan following shareholder approval - Investing.com India
Investing.com India
Phio Pharmaceuticals expands incentive plan following shareholder approval By Investing.com - Investing.com Australia
Investing.com Australia
Phio Pharmaceuticals expands incentive plan following shareholder approval - Investing.com South Africa
Investing.com South Africa
Phio Pharmaceuticals expands incentive plan following shareholder approval By Investing.com - Investing.com
Investing.com
Scotiabank ups Millicom International Cellular shares target on strong cash flow By Investing.com - Investing.com
Investing.com
Phio Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying - MSN
MSN
HireQuest CEO buys company shares worth $575 By Investing.com - Investing.com Australia
Investing.com Australia
What technical indicators reveal about PHIO stock – US Post News - US Post News
US Post News
Recent Insider Activity Could Benefit Phio Pharmaceuticals Corp (PHIO) – Knox Daily - Knox Daily
Knox Daily
Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging - The Intelligencer
The Intelligencer
Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging - Shoreline Beacon
Shoreline Beacon
Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging - Newsfile
Newsfile
Phio Pharmaceuticals Announces New Patent for INTASYL Compound That Targets Photo-aging - StockTitan
StockTitan
Phio Pharmaceuticals And 2 Other Stocks Under $2 Insiders Are Buying - Phio Pharma (NASDAQ:PHIO) - Benzinga
Benzinga
Phio Pharmaceuticals CEO buys $740 in company stock By Investing.com - Investing.com India
Investing.com India
Phio Pharmaceuticals CEO buys $740 in company stock By Investing.com - Investing.com
Investing.com
Sypris Solutions And 3 Other Stocks Under $2 Insiders Are Buying - Alset (NASDAQ:AEI) - Benzinga
Benzinga
Sypris Solutions And 3 Other Stocks Under $2 Insiders Are Buying - Alset (NASDAQ:AEI) - Benzinga
Benzinga
Phio pharmaceuticals CEO buys $750 worth of company stock - Investing.com India
Investing.com India
Phio pharmaceuticals CEO buys $750 worth of company stock By Investing.com - Investing.com
Investing.com
Phio Pharmaceuticals (NASDAQ:PHIO) Stock Price Up 2.5% - Defense World
Defense World
Market Momentum Report: Phio Pharmaceuticals Corp (PHIO)'s Positive Close at 0.75 – DWinneX - The Dwinnex
The Dwinnex
Goldman Sachs neutral on GlaxoSmithKline stock By Investing.com - Investing.com
Investing.com
Phio Pharmaceuticals advances to next dose in cancer trial By Investing.com - Investing.com
Investing.com
Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b ... - Yahoo Finance
Yahoo Finance
Phio Pharmaceuticals Announces Positive Recommendation from Safety Monitoring Committee (SMC) of Phase 1b ... - Newsfile
Newsfile
Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology ... - Yahoo Finance
Yahoo Finance
Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of Clinical Oncology ... - Yahoo Finance
Yahoo Finance
Phio Pharmaceuticals secures investment from TRITON Funds By Investing.com - Investing.com
Investing.com
Phio Pharmaceuticals Secures New Investor - GlobeNewswire
GlobeNewswire
Phio Pharmaceuticals Secures New Investor
GlobeNewswire Inc.
FY2024 EPS Estimates for Phio Pharmaceuticals Corp. (NASDAQ:PHIO) Boosted by HC Wainwright - Defense World
Defense World
Phio Pharmaceuticals Secures New Investor - GlobeNewswire
GlobeNewswire
Phio Pharmaceuticals' (PHIO) Buy Rating Reiterated at HC Wainwright - Defense World
Defense World
Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID) - GlobeNewswire
GlobeNewswire
Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID) - Yahoo Finance
Yahoo Finance
Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID) - GlobeNewswire
GlobeNewswire
Phio Pharmaceuticals Corp. Forecasted to Post Q2 2024 Earnings of ($0.51) Per Share (NASDAQ:PHIO) - Defense World
Defense World
Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation ... - GlobeNewswire
GlobeNewswire
Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation ... - Yahoo Finance
Yahoo Finance
Phio Pharmaceuticals Announces Completion of Dosing in First Patient Cohort in PH-762 Phase 1b Dose-Escalation ... - GlobeNewswire
GlobeNewswire
KalVista (KALV) Stock Continues to Decline: Here's Why - Yahoo Singapore News
Yahoo Singapore News
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update - GlobeNewswire
GlobeNewswire
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update
GlobeNewswire Inc.
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update - Yahoo Finance
Yahoo Finance
Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology (ASCO)
GlobeNewswire Inc.
Phio Pharmaceuticals Announces Upcoming Presentation at the Annual Meeting of the Society of Clinical Oncology ... - Yahoo Finance
Yahoo Finance
ServiceNow stock target cut $20, retains Outperform rating By Investing.com - Investing.com
Investing.com
Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells
GlobeNewswire Inc.
大文字化:
|
ボリューム (24 時間):